Search Form
Now choose a category »
 

Rosa DeLauro's Public Statements on Issue: Science

Office: U.S. House (CT) - District 3, Democratic
On The Ballot: Running, Democratic for U.S. House - District 3
Date Title
April 30, 2014 Letter to Gene Dodaro, Comptroller General of the United States, Government Accountability Office - Women in Clinical Research
Feb. 21, 2014 Letter to Barack Obama, President of the United States - Sustained Support for NIF
Jan. 22, 2014 Letter to Jeh Johnson, Secretary, Department of Homeland Security - Save Tax Dollars and Keep Plum Island Facility Open
May 16, 2013 Markey, House Dems Introduce Bill to Protect Human Subjects in Clinical Trials
April 23, 2012 DeLauro Visits Innovative Local Biopharmaceutical Company
May 11, 2011 Delauro: FY2012 Budget Allocations Will be Catastrophic for American Families
Feb. 6, 2010 DeLauro Reaction To Pratt & Whitney Decision
Feb. 25, 2009 Omnibus Appropriations Act, 2009
Oct. 14, 2008 Statement on Potential Conflict of Interest Surrounding BPA Decision at FDA
Sept. 25, 2008 DeLauro Statement on FDA 2009 Funding
Aug. 25, 2008 DeLauro Statement on FDA 2009 Funding
June 10, 2008 Administration Acknowledges Need for FDA Funds, Unfortunately New Budget Plan Lacks Credibility
April 2, 2008 DeLauro Holds Hearing on FDA Budget for The Center on Biologics Evaluation and Research
Dec. 12, 2005 DeLauro Urges Rigorous Oversight of Reused Medical Devices
Sept. 30, 2005 FDA Acting Commissioner Steps Down from NCI
Sept. 27, 2005 DeLauro Calls for Timeline on Naming New FDA Head
Sept. 23, 2005 Resignation of FDA Commissioner Lester Crawford
Sept. 12, 2005 DeLauro Tells FDA: Close the Gap on Medical Device Reporting
June 15, 2005 Statement of the Hon. Rosa L. DeLauro Senate Committee Vote on Lester Crawford
Skip to top
Back to top